Herbert Edward Kaufman | |
|---|---|
| Born | September 28, 1931 |
| Nationality | American |
| Alma mater | Princeton University Harvard University |
| Known for | Glaucoma, protease inhibitor, virology, Corneal transplant, Excimer laser, Photorefractive keratectomy, LASIK, Eye bank, Natamycin |
| Awards | Weisenfeld and Proctor awards from the Association for Research in Ophthalmology (ARVO)
MAP award from the Society Ophthalmoligica Montgomery Medal from the Irish Ophthalmological Society Pockington Medal from the Royal Society of Ophthalmology Innovators award from the Association of Cataract and Refractive Surgeons |
| Scientific career | |
| Fields | Ophthalmology |
| Institutions | NIH University of Florida Louisiana State University |
Herbert Edward Kaufman (September 28, 1931) is an American ophthalmologist who discovered idoxuridine, the first clinically useful antiviral agent; co-developed with William Bourne the clinical specular microscope to view the live corneal endothelium, co-developed timolol with Thomas Zimmerman, a new class of medications to treat glaucoma; corneal storage media for eye banks; natamycin, the first commercially available medication to treat fungal infections of the eye; co-developed with Tony Gasset the use of bandage contact lenses; and was involved in the first laser vision photorefractive keratectomy of the eye with Marguarite McDonald.[1][2]